InvestorsHub Logo
Followers 0
Posts 178
Boards Moderated 0
Alias Born 12/04/2013

Re: None

Wednesday, 11/08/2017 4:19:14 AM

Wednesday, November 08, 2017 4:19:14 AM

Post# of 9140
A couple of interesting questions in the CC about exclusivity. I hadn’t realised that once a big Pharma signs up with HALO on one of their drugs in a particular area then they have absolute exclusivity in that area for seemingly all time. This is potentially a problem to HALO isn’t it? Suppose a competitor comes along with a superior drug in one of those areas somewhere down the line. Then HALO can’t haloise that new drug because that area is taken. Also of course we could potentially have a Baxter type situation where a Pharma signs up in order to prevent other Pharmas in that area haloising their drugs but then decides not to market their haloised version (like HyQ or Mab/Herceptin in the US).
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News